Global awareness of peripheral arterial disease (PAD) is limited and generates a significant socioeconomic and healthcare burden [1]. Women usually present at an older age with atypical symptoms and more advanced disease in comparison with their male counterparts [2]. To highlight this fact, the American Heart Association has issued a statement imploring investigators to assess sex-based differences in PAD and identify any variation in management that could provide benefit as opposed to harm [3].